FibroGen Inc
NASDAQ:KYNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
V
|
Volkswagen AG
XHAM:VOW
|
DE |
|
B
|
Bayerische Motoren Werke AG
OTC:BAMXF
|
DE |
|
Bid Corporation Ltd
OTC:BDDDY
|
ZA |
|
A
|
Atlanta Braves Holdings Inc
NASDAQ:BATRA
|
US |
|
O
|
Osmosun SA
PAR:ALWTR
|
FR |
|
T
|
Texas Instruments Inc
SWB:TII
|
US |
|
Veeva Systems Inc
NYSE:VEEV
|
US |
|
Skeena Resources Ltd
F:RXF
|
CA |
|
Curro Holdings Ltd
F:24P
|
ZA |
|
M
|
Mitsubishi Chemical Holdings Corp
OTC:MTLHF
|
JP |
|
Solstad Maritime ASA
OTC:SLTMF
|
NO |
|
Westport Fuel Systems Inc
F:WPI
|
CA |
|
M
|
Meta Financial Group Inc
F:FM7
|
US |
|
BWX Technologies Inc
NYSE:BWXT
|
US |
|
Tri Banyan Tirta Tbk PT
IDX:ALTO
|
ID |
|
L
|
Lagardere SA
SWB:LAG
|
FR |
|
Levi Strauss & Co
NYSE:LEVI
|
US |
|
I
|
Intellia Therapeutics Inc
SWB:38I
|
US |
|
A
|
Akwel SA
LSE:0F8V
|
FR |
|
Assa Abloy AB
OTC:ASAZF
|
SE |
|
Toyota Motor Corp
TSE:7203
|
JP |
|
Stellantis NV
MIL:STLAM
|
NL |
|
R
|
Reservoir Media Inc
F:0RL0
|
US |
Bankruptcy Probability
FibroGen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
FibroGen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
FibroGen Inc
NASDAQ:FGEN
|
32.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
431.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
193.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
FibroGen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, FibroGen Inc has total debt of 19.5m USD. This includes both short-term (0 USD) and long-term (19.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
